Enhancing Access to PD-1 Blockade in India: Real-World Efficacy and Safety of a Nivolumab Biosimilar (TISHTHA) and Low-Dose Strategies (ESMO Asia 2026) - Oct 1, 2026 - Abstract #690P; Pres time: Dec 4, 2026; 05:15 PM - 06:15 PM; Location: Poster area (Exhibition); No abstract available
Clinical • Real-world • Real-world effectiveness • Real-world evidence • Oncology
|
|
S V Saju; Ramakrishnan K P; Honey S. Raju; Krishna Kumar Rathnam; Soumya Surath Panda; Akash A. Bhange; Ashwin O. Philips; Advait M. K.; Rajamony Vishanthika; Narendran Krishnamoorthi; Saraschandrabas Krupashankar; Theivasikamani Deenadayalan; Kannan Jegan Niwas; S G Ramana Shiva
|